Tweet
Hi, do you know of any service providers for NimbleGen or Agilent's SureSelect seqcap technologies?
Thanks
Thanks
-
-
Sequence capture services at Ambry Genetics
Sequence capture services at Ambry Genetics
Ambry Genetics has extensive experience with Nimblegen's sequence capture protocol using both HD2 and 385 arrays. We have worked directly with Nimblegen in the past and have performed numerous captures to date. We can prepare the library using either the standard Nimblegen adapters, or we can use our own in-house protocol for direct ligation of Illumina adapters.
Also, we are in the process of becoming an Illumina CSPro sequencing service provider.
Please contact me at [email protected] for more information.
Thanks.
Phillip -
SeqCap service
Thanks a lot, PNG. Great news! I'll contact you soon for more information.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment